Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 1, 2014, Pages 48-55

  Zhang, Ling ^a   Mai, Hua Ming ^a,c   Zheng, Jing ^b   Zheng, Jia Wei ^a   Wang, Yan An ^a   Qin, Zhong Ping ^d   Li, Ke Lei ^d  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d Linyi Tumor Hospital   (China)

Author keywords

Hemangioma stem cell; Pharmacokinetics; Propranolol; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENESIS INHIBITOR; PROPRANOLOL; VASCULOTROPIN A;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER STEM CELL; CELL CULTURE; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMANGIOMA; HEMANGIOMA-STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PHARMACOKINETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF); WESTERN BLOTTING;

HEMANGIOMA-STEM CELL; PHARMACOKINETICS; PROPRANOLOL; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMANGIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; PROPRANOLOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904266902     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol 2011; 25: 1245-1253
2. Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden IJ. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118: 882-887
3. Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC, Mulliken JB, Bischoff J. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008; 118: 2592-2599
4. Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med 2010; 362: 1005-1013
5. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651
6. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as first-line treatment for rapidly proliferating Infantile Haemangiomas. J Plast Reconstr Aesthet Surg 2011; 64: 445-451
7. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into themolecular mechanisms of action. Br J Dermatol 2010; 163: 269-274
8. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells in Vitro. Cell Dev Biol Anim 2002; 38: 298-304
9. Lamy S, Lachambre MP, Lord-Dufour S, Béliveau R. Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration and differentiation of endothelial cells. Vascular Pharmacology 2010; 53: 200-208
10. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001; 53: 319-356
11. Wolter NE, Wolter JK, Enepekides DJ, Irwin MS. Propranolol as a novel adjunctive treatment for head and neck squamous cell carcinoma. J Otolaryngol Head Neck Surg 2012; 41: 334-344
12. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9-22
13. Frieden IJ, Haggstrom AN, Drolet BA, Mancini AJ, Friedlander SF. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas. Pediatr Dermatol 2005; 22: 383-406
14. Chang J, Most D, Bresnick S, Mehrara B, Steinbrech DS, Reinisch J, Longaker MT, Turk AE. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg 1999; 103: 1-9
15. Przewratil P, Sitkiewicz A, Wyka K, Andrzejewska E. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations-preliminary report. Pediatr Dermatol 2009; 26: 399-404
16. Wang K, Zheng J. Signaling regulation of fetoplacental angiogenesis. J Endocrinol 2012; 212: 243-255
17. Yamashita H, Sato N, Kizaki T, Oh-ishi S, Segawa M, Saitoh D, Ohira Y, Ohno H. Norepinephrine stimulates the expression of fibroblast growth factor 2 in rat brown adipocyte primary culture. Cell Growth Differ 1995; 6: 1457-1462
18. Follesa P, Mocchetti I. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by β-adrenergic receptor activation and adrenal steroids in rat central nervous system. Mol Pharmacol 1993; 43: 132-138